Get the Stockscreener App
4.99
2.16%
-0.11
Overview
News
Price History
Option Chain
Financials
Why BHC Down?
Discussions
Forecast
Stock Split
Dividend History
Bausch Health Companies Inc stock is traded at $4.99, with a volume of 1.16M.
It is down -2.16% in the last 24 hours and down -17.11% over the past month.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
See More
Previous Close:
$5.10
Open:
$5.05
24h Volume:
1.16M
Relative Volume:
0.50
Market Cap:
$1.85B
Revenue:
$10.27B
Net Income/Loss:
$120.00M
P/E Ratio:
12.05
EPS:
0.4142
Net Cash Flow:
$949.99M
1W Performance:
-3.67%
1M Performance:
-17.11%
6M Performance:
-24.96%
1Y Performance:
-31.36%
1-Day Range:
$4.93
$5.05
1-Week Range:
$4.93
$5.19
52-Week Range:
$4.25
$8.685
Bausch Health Companies Inc Stock (BHC) Company Profile
Name
Bausch Health Companies Inc
Sector
Phone
514-744-6792
Address
2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC
Compare BHC vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BHC
Bausch Health Companies Inc
|
4.99 | 1.85B | 10.27B | 120.00M | 949.99M | 0.4142 |
TAK
Takeda Pharmaceutical Co Adr
|
18.04 | 56.99B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
115.93 | 48.94B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.70 | 43.30B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.14 | 33.94B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
531.82 | 23.31B | 3.18B | 1.33B | 1.04B | 27.90 |
Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Equal Weight |
| Aug-02-24 | Downgrade | Piper Sandler | Neutral → Underweight |
| Jul-10-24 | Initiated | Raymond James | Mkt Perform |
| Sep-20-23 | Upgrade | Jefferies | Hold → Buy |
| Jun-16-23 | Downgrade | TD Cowen | Outperform → Market Perform |
| Jul-29-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jul-29-22 | Downgrade | Truist | Buy → Hold |
| Jul-28-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-13-22 | Resumed | JP Morgan | Overweight |
| Mar-24-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Feb-17-21 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jan-22-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-17-20 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-24-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-17-20 | Reiterated | H.C. Wainwright | Buy |
| Apr-24-20 | Initiated | Citigroup | Buy |
| Apr-02-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-29-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jan-22-20 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Dec-12-19 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-02-19 | Initiated | Goldman | Neutral |
| Oct-25-19 | Initiated | Cowen | Outperform |
| Sep-12-19 | Initiated | Guggenheim | Buy |
| Aug-15-19 | Upgrade | TD Securities | Hold → Buy |
| Jul-19-19 | Initiated | Wolfe Research | Outperform |
| Jun-11-19 | Resumed | Barclays | Overweight |
| May-13-19 | Upgrade | JP Morgan | Underweight → Neutral |
| Mar-20-19 | Initiated | SunTrust | Buy |
| Jan-02-19 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Nov-05-18 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-13-18 | Upgrade | Piper Jaffray | Underweight → Neutral |
View All
Bausch Health Companies Inc Stock (BHC) Latest News
Is the Options Market Signaling a Surge for Bausch Health Shares? - Bitget
Is the Options Market Predicting a Spike in Bausch Health Stock? - TradingView
EPS Watch: Is Bausch Health Companies Inc subject to activist investor interest2026 Price Momentum & Verified High Yield Trade Plans - baoquankhu1.vn
Published on: 2026-03-21 08:43:51 - baoquankhu1.vn
Surprises Report: How does Bausch Health Companies Inc perform in inflationary periods2026 Key Lessons & Daily Stock Momentum Reports - baoquankhu1.vn
Heavy Metal Poisoning Treatment Market Outlook: Oral - openPR.com
BHC Stock Price, Quote & Chart | BAUSCH HEALTH COS INC (NYSE:BHC) - ChartMill
Bausch Health Cos Inc. $BHC is Goldentree Asset Management LP's Largest Position - MarketBeat
Aug Big Picture: What drives Bausch Health Companies Incs stock priceWeekly Stock Report & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
Merger Talk: Is Bausch Health Companies Inc subject to activist investor interestQuarterly Trade Report & Community Verified Watchlist Alerts - baoquankhu1.vn
Aug Momentum: Is Bausch Health Companies Inc backed by strong institutional buying2026 Analyst Calls & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
VIX Spike: Can Bausch Health Companies Inc expand into new marketsEarnings Growth Report & Fast Moving Stock Trade Plans - baoquankhu1.vn
Separation overhang continues to weigh on Bausch Health Companies Inc. (BHC) outlook - MSN
Bausch Health Cos Inc. $BHC Shares Sold by Compass Rose Asset Management LP - MarketBeat
Q2 EPS Forecast for Bausch Health Cos Decreased by Analyst - MarketBeat
Zacks Research Issues Positive Estimate for TSE:BHC Earnings - MarketBeat
Zacks Research Expects Lower Earnings for Bausch Health Cos - MarketBeat
Zacks Research Has Pessimistic View of TSE:BHC Q1 Earnings - MarketBeat
Growth Value: Is Bausch Health Companies Inc impacted by rising ratesRecession Risk & Safe Entry Point Alerts - baoquankhu1.vn
Pfizer, Teva lose bid to disqualify ex-prosecutor in generic drug price‑fixing case - Reuters
Bausch Health Companies (TSE:BHC) Stock Price Down 1.1%Here's What Happened - MarketBeat
Bausch Health (BHC) announces global phase 3 RED-C clinical program results - MSN
Bausch Health to redeem ~$602M of outstanding notes due 2026 - MSN
How analysts rate Bausch Health Companies Inc. stock todayAnalyst Upgrade & Step-by-Step Trade Execution Guides - Naître et grandir
Vanguard Group Inc. Has $78.81 Million Stock Holdings in Bausch Health Cos Inc. $BHC - MarketBeat
Bausch Health expects 3% revenue growth in 2026 while strengthening balance sheet and expanding in China - MSN
BHC SEC FilingsBausch Health Companies Inc 10-K, 10-Q, 8-K Forms - Stock Titan
List of 22 Acquisitions by Bausch Health (Mar 2026) - Tracxn
Bausch Health (NYSE: BHC) CFO reports tax-withholding share disposition - Stock Titan
Bausch Health (BHC) EVP Carson trades shares, settles equity awards - Stock Titan
Tax withholding and cash PSU settlement for Bausch Health (BHC) CEO - Stock Titan
Seana Carson reports sales of 8,388 and 6,856 shares — BHC (NYSE: BHC) - Stock Titan
Bausch Health updates executive compensation agreements to cash settlement for 2023 PSUs - Investing.com Canada
Bausch Health updates executive compensation agreements to cash settlement for 2023 PSUs By Investing.com - Investing.com Australia
Bausch Health (NYSE: BHC) converts 2023 executive PSUs into cash-settled awards - Stock Titan
Bausch Health (NYSE:BHC) Stability Story Amid Canada Pharma Shifts Nyse Composite Today - Kalkine Media
Proposed insider sale at BHC (NYSE: BHC) — 6,856 common shares - Stock Titan
Bausch Health Cos Inc. (NYSE:BHC) Receives Average Rating of "Reduce" from Analysts - MarketBeat
Is Bausch Health (BHC) Pricing Reflect Its Sharp Multi‑Year Share Price Declines? - Sahm
Assessing Bausch Health (BHC) Valuation After Years Of Weak Returns And Ongoing Debt Reduction Efforts - Sahm
Bausch Health (BHC) SVP Steven Lee receives 45,868 restricted share units - Stock Titan
Bausch Health (NYSE: BHC) EVP receives RSU grant, tax shares withheld - Stock Titan
Insider moves at Bausch Health (BHC): RSU grant, tax shares, open-market sale - Stock Titan
Bausch Health (NYSE: BHC) CFO awarded RSUs; shares withheld for tax obligations - Stock Titan
Should Bausch Health’s Profit Return and 2026 Outlook Shift the Investment Case for BHC? - Yahoo Finance
BHC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Bausch Health Cos (NYSE:BHC) Price Target Cut to $7.00 by Analysts at Barclays - MarketBeat
Signal Recap: Is now the right time to enter SAIAQuarterly Market Summary & Daily Entry Point Trade Alerts - baoquankhu1.vn
EV Market: Is Bausch Health Companies Inc backed by strong institutional buyingMarket Volume Summary & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Bausch Health Companies Inc. (BHC) Stock Analysis: Exploring a 31.39% Potential Upside for Savvy Investors - DirectorsTalk Interviews
Trading Recap: Is Bausch Health Companies Inc stock a value trapJuly 2025 Gainers & Free Community Consensus Stock Picks - baoquankhu1.vn
Bausch Health Companies Inc Stock (BHC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.75%
1.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):